Đang chuẩn bị liên kết để tải về tài liệu:
TRAITEMENT MEDICAMENTEUX DU DIABETE DE TYPE 2 - PART 3

Cơ sở di truyền của loại 2 bệnh tiểu đường. Curr Opin Endocrinol Diab năm 1998; 5: 116-25 38. N. C. Hales, Barker D.J.P., P. M. S. Clark, et al. Thai nhi và trẻ sơ sinh tăng trưởng và dung nạp glucose ở tuổi 64. B M J năm 1991; 303: 1019-1022 39. Garofano A., P. Czernichow, B. Bréant Suy dinh dưỡng trong tử cung phát triển của tế bào beta lẻ chuột. | Traitement medicamenteux du diabete de type 2 Actualisation Argumentaire 37. Elbein S.C. An update on the genetic basis of type 2 diabetes. Curr Opin Endocrinol Diab 1998 5 116-25 38. Hales C.N. Barker D.J.P. Clark P.M.S. et al. Fetal and infant growth and impaired glucose tolerance at age 64. B M J 1991 303 1019-22 39. Garofano a. Czernichow P. Breant B. In utero undernutrition impairs rat beta-cell development. Diabetologia 1997 40 1231-4 40. Gerich J.E. Insulin resistance is not necessarily an essential component of type 2 diabetes. J Clin Endocrinol Metab 2000 85 2113-5 41. Wingard D.L. Sinsheimer P. Barret-Connor E.L. et al. Community-based study of prevalence of NIDDM in older adults. Diabetes Care 1990 13 suppl. 2 3-8 42. Pan XR Li GW Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 1997 20 537-44 43. Tuomilheto J Lindstrom J Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 344 1343-50 44. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 346 393-403 45. Kahn BB Flier JS. Obesity and insulin resistance. J Clin Invest 2000 106 473-481 46. Shulman G I. Cellular mechanisms of insulin resistance. J Clin Invest 2000 106 171-6 47. Kahn C.R. Insulin action diabetogenes and the cause of type II diabetes. Diabetes 1994 43 1066-1084. 48. Gerich J.E. Insulin resistance is not necessarily an essential component of type 2 diabetes. J Clin Endocrinol Metab 2000 85 2113-5 49. Weyer C Bogardus C. Mott D.M. et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 1999 104 787-797. 50. Henriksen J Alford F. Ward G. et al. Risk and mechanism of dexamethasone induced deterioration of .